Ok I found the time to read the whole document and here is one part I found interesting......
Sorry for the big quote but I feel this is very telling.
"“In order to further validate vaccine related illnesses, fuller studies would be required.”
Despite these unresolved safety issues, the conclusion reached at the meeting was that:
“There should be no change in the present recommendations or supply of MMR vaccine on
the evidence available to us at the present time.”
Thus, instead of re-evaluating the vaccination policy, at least until safety concerns were
fully evaluated, the JCVI choose to support the existing policy based on incomplete
evidence that was available at that time.
Furthermore, at the 17th September 1990 meeting (www.dh.gov.uk...
DH_095294), the JCVI appeared to have been fully aware of increasing numbers of cases of
mumps vaccine-associated aseptic meningitis occurring in Japan, since at the time of the
meeting, they had been presented with a draft of a study by Sugiura et al. . The
Japanese study found that among 630,157 recipients of the MMR vaccine containing the
Urabe-9 mumps vaccine, there were at least 311 meningitis cases suspected to be vaccinerelated.
In 96 of these 311 cases, mumps virus related to the vaccine was isolated from the
CSF. Sugiura et al.  noted that this was an unusually high incidence of vaccine-related
adverse outcomes, which they had attributed in part to “adverse media publicity”.
Nonetheless, the fact that in almost one third of the cases, the vaccine strain had been
isolated from the CSF of children, suggests that safety concerns over the MMR were
warranted. Indeed, in 1993 the Japanese suspended the use of the MMR vaccines containing
the Urabe strain due to it causing a high incidence of aseptic meningitis, and reverted to
the use of monovalent measles, mumps and rubella vaccines. According to Japanese Health
Authorities, the withdrawal of the MMR had not caused an increase in deaths from wild
measles infection. Noteworthy, in a BBC news report (news.bbc.co.uk...
1808316.stm), a spokesperson for the Japan’s Health Ministry stated that:
“...more children had died from the disease during the period when MMR was being used.”
In reference to the Japanese study, the JCVI transcript specifically states:
“The paper confirmed information from Japan previously disclosed to ARVI.”
This suggests that the JCVI knew for some time that the Urabe-9 vaccine was causing
problems and yet, did not consider the possibility to temporarily suspend its use.
Furthermore, four months prior to the 17th September 1990 meeting, at the JCVI 4th May 1990
), ARVI expressed concerns regarding the reports
from Japan. The major reason for these concerns was not that the JCVI/ARVI were in favour of
using the Urabe-9 vaccine which was now associated with increased risk of meningitis/encephalitis
in children, but rather:
“Professor Banatvala was concerned about the possibility of the Japanese experience being
published widely in the UK, and urged the gathering of information on the various episodes"
There is some very scary stuff in this PDF and I could spend all night copying and pasting but you get the gist of the issue....
Again thanks to the OP for bringing this to the table.